Concepedia

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

Unknown author(s)

New England Journal of Medicine · 2006 · 1.7K citations · 10 references

DOIFull text

Open access

Abstract

Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease. (ClinicalTrials.gov number, NCT00106886; Current Controlled Trials number, ISRCTN14017017.).

References

10

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Stephen B. Hulley · JAMA · 1998 · 6.2K citations

Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction

Elliott M. Antman, Jean‐Pierre Bassand, Werner Klein et al. · Journal of the American College of Cardiology · 2000 · 4.8K citations

, , +11

Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction

Kaare Harald Bønaa, Inger Njølstad, Per Magne Ueland et al. · New England Journal of Medicine · 2006 · 1.4K citations · Full text

Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death

James F. Toole, M.R. Malinow, Lloyd E. Chambless et al. · JAMA · 2004 · 1.4K citations

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

Carol J. Boushey · JAMA · 1995 · 770 citations

, , +19